The authors reported that siRNA-mediated ADAM10 knockdown reduced PrPC shedding and increased Aβ oligomer binding whereas acitretin promoted PrPC shedding and decreased Aβ oligomer binding in the neuroblastoma cells and in human-induced pluripotent stem cells [82]. The gene discussed is PRNP; the disease is neuroblastoma.